- Home
- VNRX vs CVM Comparison
VNRX vs CVM Comparison
Compare VNRX & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- CVM
- Stock Information
- Founded
- VNRX N/A
- CVM 1983
- Country
- VNRX United States
- CVM United States
- Employees
- VNRX N/A
- CVM N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VNRX Health Care
- CVM Health Care
- Exchange
- VNRX Nasdaq
- CVM Nasdaq
- Market Cap
- VNRX 64.8M
- CVM 71.2M
- IPO Year
- VNRX N/A
- CVM 1987
- Fundamental
- Price
- VNRX $0.63
- CVM $9.80
- Analyst Decision
- VNRX Strong Buy
- CVM
- Analyst Count
- VNRX 4
- CVM 0
- Target Price
- VNRX $3.50
- CVM N/A
- AVG Volume (30 Days)
- VNRX 200.3K
- CVM 294.7K
- Earning Date
- VNRX 11-13-2025
- CVM 08-14-2025
- Dividend Yield
- VNRX N/A
- CVM N/A
- EPS Growth
- VNRX N/A
- CVM N/A
- EPS
- VNRX N/A
- CVM N/A
- Revenue
- VNRX $1,319,252.00
- CVM N/A
- Revenue This Year
- VNRX $274.46
- CVM N/A
- Revenue Next Year
- VNRX $212.60
- CVM N/A
- P/E Ratio
- VNRX N/A
- CVM N/A
- Revenue Growth
- VNRX 35.10
- CVM N/A
- 52 Week Low
- VNRX $0.40
- CVM $1.98
- 52 Week High
- VNRX $0.94
- CVM $38.70
- Technical
- Relative Strength Index (RSI)
- VNRX 46.17
- CVM 51.15
- Support Level
- VNRX $0.57
- CVM $9.58
- Resistance Level
- VNRX $0.73
- CVM $10.48
- Average True Range (ATR)
- VNRX 0.05
- CVM 1.25
- MACD
- VNRX -0.00
- CVM -0.29
- Stochastic Oscillator
- VNRX 37.56
- CVM 23.81
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.